研究单位:[1]Peking Union Medical College Hospital[2]Beijing Tongren Hospital[3]Chinese Academy of Medical Sciences,Fuwai Hospital[4]The Luhe Teaching Hospital of the Capital Medical University[5]The Seventh Affiliated Hospital of Sun Yat-sen University[6]First Affiliated Hospital of Xinjiang Medical University[7]Nanyang Nanshi Hospital of Henan University[8]Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
The primary objective of this study is to determine whether or not cyclosporine (CsA) combined with RTX is more effective than RTX alone in the treatment of idiopathic membranous nephropathy (iMN).